| Christina A Kraft, PHD | |
|
444 N Main St, Suite 408, Akron, OH 44310-3110 | |
| (330) 379-8190 | |
| (330) 379-8191 |
| Full Name | Christina A Kraft |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 18 Years |
| Location | 444 N Main St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972767499 | NPI | - | NPPES |
| 2887498 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | P6454 (Ohio) | Primary |
| Entity Name | Ohio Psychiatry Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639502529 PECOS PAC ID: 6800022419 Enrollment ID: O20131203001379 |
News Archive
The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community.
In the Philippines, in the early months of the COVID-19 pandemic, there occurred a supply shortage of hydroxychloroquine and methotrexate. Limited access to medication and the life changes caused from the COVID-19 pandemic may prompt patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) to experience disease flares.
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.
Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina A Kraft, PHD 4807 Rockside Rd, Ste 300, Independence, OH 44131-6802 Ph: (216) 503-9489 | Christina A Kraft, PHD 444 N Main St, Suite 408, Akron, OH 44310-3110 Ph: (330) 379-8190 |
News Archive
The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new translational research platform to study rare cancers and develop a first-of-its-kind resource for the scientific community.
In the Philippines, in the early months of the COVID-19 pandemic, there occurred a supply shortage of hydroxychloroquine and methotrexate. Limited access to medication and the life changes caused from the COVID-19 pandemic may prompt patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) to experience disease flares.
DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.
Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.
› Verified 4 days ago
Mr. Terry Bendo, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1372 Delia Ave, Akron, OH 44320 Phone: 330-761-3067 | |
Jessica Feinstein, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 214 W Bowery St, Akron, OH 44308 Phone: 330-543-1000 | |
Dr. Alan Dale Gilbertson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6525 Fax: 330-996-2943 | |
Alanna G Updegraff, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 | |
Elizabeth R. Holmes, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2108 Braewick Cir, Ste 202, Akron, OH 44313 Phone: 330-920-9292 Fax: 330-920-9393 | |
James Anthony Orlando, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 37 N Broadway St, Akron, OH 44308 Phone: 330-535-8181 Fax: 330-535-9303 | |
Dr. Kevin Triemstra, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4270 Fax: 330-543-4271 |